Body advises MHRA on patient information leaflets and yellow cards

摘要

A new body set up to give the Medicines and Healthcare products Regulatory Agency independent expert advice on how patient information leaflets(PILs)can be improved,met for the first time last week.The Patient Information Expert Advisory Group(PIEAG)is part of the Commission on Human Medicines.Its aim is to look at ways to improve PILs and to offer advice on how the MHRA communicates the risk/benefit ratio of medicines to patients.The group will also advise the MHRA on how to encourage patients to use the Yellow Card Scheme to report suspected adverse effects.